The Institute of Molecular Medicine is a research unit associated with the Faculty of Medicine of Lisbon University and Santa Maria Hospital. Its main goal is to promote basic, clinical, and translational biomedical research, in order to develop and enhance the knowledge of diseases, diagnostics, and treatments
Involved in the clinical observational study:
– Recruitment of participants;
– Coordinating the COS in Portugal.
Target recruitment:
• Parkinson’s disease – 70
• Huntington’s disease – 30
• Healthy controls – 5
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.